Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Parkinsonism & Related Disorders
|
March 15, 2016
Do patients with late-stage Parkinson's disease still respond to levodopa?
Margherita Fabbri, Miguel Coelho, Daisy Abreu, et al.
Pediatric Pulmonology
|
November 24, 2015
Acute viral bronchiolitis: Physician perspectives on definition and clinically important outcomes
Ricardo M Fernandes, Maria Gabriela Andrade, Carolina Constant, et al.
Neurology
|
May 12, 2017
Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis
Maria A Silva, Gonçalo S Duarte, Raquel Camara, et al.
Parkinsonism & Related Disorders
|
April 9, 2017
Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test
Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, et al.
Frontiers in Neurology
|
September 8, 2017
Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease
Margherita Fabbri, Isabel Guimarães, Rita Cardoso, et al.
Parkinsonism & Related Disorders
|
March 24, 2019
Dysphagia predicts poor outcome in late-stage Parkinson's disease
Margherita Fabbri, Miguel Coelho, Daisy Abreu, et al.
Frontiers in Neurology
|
August 2, 2021
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
Daisy Abreu, Jennifer Ware, Nellie Georgiou-Karistianis, et al.
Journal of Parkinson'S Disease
|
September 26, 2015
Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease
Sofia Reimão, Patrícia Pita Lobo, Dulce Neutel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 12, 2015
Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease
Sofia Reimão, Patrícia Pita Lobo, Dulce Neutel, et al.
Journal of Parkinson'S Disease
|
July 4, 2017
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
Margherita Fabbri, Sofia Reimão, Miguel Carvalho, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Parkinsonism & Related Disorders
|
March 15, 2016
Do patients with late-stage Parkinson's disease still respond to levodopa?
Margherita Fabbri, Miguel Coelho, Daisy Abreu, et al.
Pediatric Pulmonology
|
November 24, 2015
Acute viral bronchiolitis: Physician perspectives on definition and clinically important outcomes
Ricardo M Fernandes, Maria Gabriela Andrade, Carolina Constant, et al.
Neurology
|
May 12, 2017
Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis
Maria A Silva, Gonçalo S Duarte, Raquel Camara, et al.
Parkinsonism & Related Disorders
|
April 9, 2017
Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test
Margherita Fabbri, Miguel Coelho, Leonor Correia Guedes, et al.
Frontiers in Neurology
|
September 8, 2017
Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease
Margherita Fabbri, Isabel Guimarães, Rita Cardoso, et al.
Parkinsonism & Related Disorders
|
March 24, 2019
Dysphagia predicts poor outcome in late-stage Parkinson's disease
Margherita Fabbri, Miguel Coelho, Daisy Abreu, et al.
Frontiers in Neurology
|
August 2, 2021
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
Daisy Abreu, Jennifer Ware, Nellie Georgiou-Karistianis, et al.
Journal of Parkinson'S Disease
|
September 26, 2015
Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease
Sofia Reimão, Patrícia Pita Lobo, Dulce Neutel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 12, 2015
Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease
Sofia Reimão, Patrícia Pita Lobo, Dulce Neutel, et al.
Journal of Parkinson'S Disease
|
July 4, 2017
Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease
Margherita Fabbri, Sofia Reimão, Miguel Carvalho, et al.
Page
of 4